Wall Street brokerages forecast that Anthem Inc (NYSE:ANTM) will post sales of $26.85 billion for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for Anthem’s earnings. The highest sales estimate is $27.22 billion and the lowest is $25.93 billion. Anthem posted sales of $23.30 billion in the same quarter last year, which would indicate a positive year-over-year growth rate of 15.2%. The firm is scheduled to announce its next earnings results on Wednesday, January 29th.
According to Zacks, analysts expect that Anthem will report full year sales of $102.82 billion for the current financial year, with estimates ranging from $101.94 billion to $103.23 billion. For the next fiscal year, analysts anticipate that the company will post sales of $114.98 billion, with estimates ranging from $112.75 billion to $116.73 billion. Zacks’ sales calculations are a mean average based on a survey of research analysts that cover Anthem.
Anthem (NYSE:ANTM) last announced its quarterly earnings data on Wednesday, October 23rd. The company reported $4.87 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $4.82 by $0.05. Anthem had a return on equity of 15.59% and a net margin of 4.29%. The firm had revenue of $26.44 billion for the quarter, compared to analysts’ expectations of $25.88 billion. During the same period last year, the business posted $3.81 earnings per share. The firm’s revenue for the quarter was up 15.1% on a year-over-year basis.
Several research analysts have recently commented on the stock. Credit Suisse Group decreased their price target on shares of Anthem from $345.00 to $340.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. Mizuho assumed coverage on shares of Anthem in a research note on Thursday, October 17th. They set a “neutral” rating and a $262.00 price objective on the stock. Morgan Stanley cut their target price on shares of Anthem from $371.00 to $356.00 and set an “overweight” rating on the stock in a report on Thursday, September 26th. Zacks Investment Research downgraded Anthem from a “buy” rating to a “hold” rating and set a $289.00 target price for the company. in a research note on Monday, August 19th. Finally, Deutsche Bank assumed coverage on Anthem in a research note on Thursday, September 12th. They issued a “buy” rating for the company. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $317.46.
In other Anthem news, EVP Peter D. Haytaian sold 12,095 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $300.00, for a total value of $3,628,500.00. Following the sale, the executive vice president now owns 41,377 shares in the company, valued at $12,413,100. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Ronald W. Penczek sold 816 shares of the firm’s stock in a transaction that occurred on Wednesday, November 13th. The shares were sold at an average price of $287.00, for a total transaction of $234,192.00. Following the completion of the sale, the chief accounting officer now owns 2,295 shares in the company, valued at approximately $658,665. The disclosure for this sale can be found here. Insiders have sold a total of 22,497 shares of company stock valued at $6,446,790 over the last three months. 0.17% of the stock is currently owned by company insiders.
A number of hedge funds have recently modified their holdings of ANTM. Vanguard Group Inc. increased its holdings in shares of Anthem by 0.8% during the second quarter. Vanguard Group Inc. now owns 19,470,785 shares of the company’s stock valued at $5,494,850,000 after purchasing an additional 146,654 shares during the period. Barrow Hanley Mewhinney & Strauss LLC grew its position in Anthem by 101.2% in the 2nd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 3,821,672 shares of the company’s stock valued at $1,078,514,000 after buying an additional 1,921,814 shares in the last quarter. Northern Trust Corp grew its position in Anthem by 1.5% in the 2nd quarter. Northern Trust Corp now owns 3,169,731 shares of the company’s stock valued at $894,530,000 after buying an additional 47,621 shares in the last quarter. Bank of New York Mellon Corp grew its position in Anthem by 9.3% in the 2nd quarter. Bank of New York Mellon Corp now owns 2,582,640 shares of the company’s stock valued at $728,848,000 after buying an additional 219,003 shares in the last quarter. Finally, Boston Partners increased its stake in Anthem by 33.9% during the 2nd quarter. Boston Partners now owns 2,437,084 shares of the company’s stock valued at $688,249,000 after buying an additional 617,137 shares during the period. 88.29% of the stock is owned by institutional investors and hedge funds.
Shares of NYSE:ANTM opened at $286.30 on Friday. The company’s fifty day moving average is $277.57 and its two-hundred day moving average is $274.05. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.70 and a current ratio of 1.70. Anthem has a 1-year low of $227.16 and a 1-year high of $317.99. The stock has a market capitalization of $73.19 billion, a price-to-earnings ratio of 18.02, a price-to-earnings-growth ratio of 1.06 and a beta of 0.76.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Thursday, December 5th will be given a $0.80 dividend. The ex-dividend date is Wednesday, December 4th. This represents a $3.20 annualized dividend and a yield of 1.12%. Anthem’s dividend payout ratio is presently 20.14%.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Featured Article: Can individual investors take part in an IPO?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.